Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.640
-0.020 (-1.20%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Fortress Biotech Revenue
In the year 2024, Fortress Biotech had annual revenue of $57.68M, down -31.76%. Fortress Biotech had revenue of $15.12M in the quarter ending December 31, 2024, a decrease of -61.18%.
Revenue (ttm)
$57.68M
Revenue Growth
-31.76%
P/S Ratio
0.59
Revenue / Employee
$571,040
Employees
101
Market Cap
48.44M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 57.68M | -26.84M | -31.76% |
Dec 31, 2023 | 84.51M | 8.77M | 11.58% |
Dec 31, 2022 | 75.74M | 6.95M | 10.11% |
Dec 31, 2021 | 68.79M | 23.19M | 50.86% |
Dec 31, 2020 | 45.60M | 8.97M | 24.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
FBIO News
- 26 days ago - Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer - GlobeNewsWire
- 27 days ago - Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 4 weeks ago - Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 4 weeks ago - Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 4 weeks ago - Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea - GlobeNewsWire
- 5 weeks ago - Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - GlobeNewsWire
- 5 weeks ago - Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform - GlobeNewsWire